Gita Suneja1, Anna Coghill. 1. aDepartment of Radiation Oncology, Duke University, Duke Global Health Institute, Durham, North Carolina, USA bNational Cancer Institute, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Cancer is a growing problem in the HIV population, in large part because of aging of HIV-infected people treated with antiretroviral therapy. Overall and cancer-specific survival is worse in HIV-infected cancer patients compared with uninfected patients. One potential reason for the observed survival deficit is differences in cancer treatment. RECENT FINDINGS: Recent population-based data suggest that HIV-infected cancer patients are less likely to receive cancer treatment compared with uninfected patients. This review describes these treatment disparities and their impact on patient outcomes, explores reasons for the disparity and highlights areas for future research. SUMMARY: Cancer is the leading cause of non-AIDS death in HIV-infected individuals. Understanding the underlying cancer treatment disparity between HIV-infected patients and their uninfected counterparts, and developing solutions to address the problem, is of great importance to improve cancer outcomes in this growing patient population.
PURPOSE OF REVIEW: Cancer is a growing problem in the HIV population, in large part because of aging of HIV-infected people treated with antiretroviral therapy. Overall and cancer-specific survival is worse in HIV-infected cancerpatients compared with uninfected patients. One potential reason for the observed survival deficit is differences in cancer treatment. RECENT FINDINGS: Recent population-based data suggest that HIV-infected cancerpatients are less likely to receive cancer treatment compared with uninfected patients. This review describes these treatment disparities and their impact on patient outcomes, explores reasons for the disparity and highlights areas for future research. SUMMARY:Cancer is the leading cause of non-AIDS death in HIV-infected individuals. Understanding the underlying cancer treatment disparity between HIV-infectedpatients and their uninfected counterparts, and developing solutions to address the problem, is of great importance to improve cancer outcomes in this growing patient population.
Authors: Kelsey L Corrigan; Leticia Nogueira; K Robin Yabroff; Chun Chieh Lin; Xuesong Han; Junzo P Chino; Anna E Coghill; Meredith Shiels; Ahmedin Jemal; Gita Suneja Journal: Cancer Date: 2019-11-11 Impact factor: 6.860
Authors: Kimberly L Levinson; David J Riedel; Laureen S Ojalvo; Wesley Chan; Ana M Angarita; Amanda N Fader; Anne F Rositch Journal: AIDS Date: 2018-01-14 Impact factor: 4.177
Authors: Cristina E Brickman; Kathleen J Propert; Jessica S Merlin; Jeffrey C Liu; Sequoya Eady; Amy Mcghee-Jez; Camille Ragin; Surbhi Grover; Roger B Cohen; Robert Gross Journal: AIDS Res Hum Retroviruses Date: 2019-08-29 Impact factor: 2.205
Authors: Qianlai Luo; Ruth M Pfeiffer; Anne-Michelle Noone; Marie-Josèphe Horner; Eric A Engels; Meredith S Shiels Journal: AIDS Date: 2022-05-25 Impact factor: 4.632
Authors: Yoanna S Pumpalova; Leslie Segall; Richard Felli; Gauri Bhatkhande; Judith S Jacobson; Alfred I Neugut Journal: Semin Oncol Date: 2021-09-22 Impact factor: 5.385
Authors: Amber Chi; Bryan E Adams; Joanna Sesti; Subroto Paul; Amber L Turner; David August; Darren Carpizo; Timothy Kennedy; Miral Grandhi; H Richard Alexander; Steven K Libutti; Stuart Geffner; Russell C Langan Journal: World J Surg Date: 2019-12 Impact factor: 3.352